
NovelStem International
(OTC) NSTM
NovelStem International Financials at a Glance
Market Cap
$444.00K
Revenue (TTM)
$0.00
Net Income (TTM)
$2.53M
EPS (TTM)
$0.05
P/E Ratio
0.17
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Price
$0.01
Volume
57,377
Open
$0.01
Price
$0.01
Volume
57,377
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.04
Estimated Earnings Date
May 18, 2026
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Price
$0.01
Volume
57,377
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.04
Estimated Earnings Date
May 18, 2026
NSTM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NovelStem International
Industry
Biotechnology
Sector
Health CareCEO
Ayelet Dilion-Mashiah
Website
www.novelstem.comHeadquarters
Boca Raton, FL 33431, US
NSTM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
8%
Return on Assets
25%
Earnings Yield
5.88%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$444.00K
Shares Outstanding
49.33M
Volume
57.38K
Avg. Volume
7.52K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$238.76K
EBITDA
-$238.76K
Operating Cash Flow
-$167.63K
Capital Expenditure
$0.00
Free Cash Flow
-$167.63K
Cash & ST Invst.
$333.00
Total Debt
$1.73M
NovelStem International Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$444.00K
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
-$55.02K
+73.4%
EBITDA
-$4.95K
+94.8%
Quarterly Fundamentals
Total Cash
$89.85K
+2541.9%
Total Debt
$1.78M
-61.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$1.78M
-61.4%
Return on Assets
25.09%
N/A
Return on Invested Capital
8.50%
N/A
Free Cash Flow
-$138.73K
-217.5%
Operating Cash Flow
-$138.73K
-217.5%